Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Another Vaccine Looking Hopeful
29 Apr 2020
UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
This article was first published by University of Queensland.
The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
UQ was tasked by the Coalition for Epidemic Preparedness Innovation (CEPI) to use its vaccine technology to develop a coronavirus vaccine, and has collaborated with the Peter Doherty Institute for Infection and Immunity (Doherty Institute) to demonstrate and understand its immune response.
UQ project co-leader Professor Paul Young said the results were an excellent indication that the vaccine worked as expected.
“This is what we were hoping for, and it’s a great relief for the team given the tremendous faith placed in our technology by CEPI, Federal and Queensland Governments and our philanthropic partners,” Professor Young said.
“We were particularly pleased that the strength of the antibody response was even better than those observed in samples from COVID-19 recovered patients.”
https://www.doherty.edu.au/news-events/news/uq-covid-19-vaccine-shown-to-induce-potent-protective-response-in-pre-clinical-trials
UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
This article was first published by University of Queensland.
The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
UQ was tasked by the Coalition for Epidemic Preparedness Innovation (CEPI) to use its vaccine technology to develop a coronavirus vaccine, and has collaborated with the Peter Doherty Institute for Infection and Immunity (Doherty Institute) to demonstrate and understand its immune response.
UQ project co-leader Professor Paul Young said the results were an excellent indication that the vaccine worked as expected.
“This is what we were hoping for, and it’s a great relief for the team given the tremendous faith placed in our technology by CEPI, Federal and Queensland Governments and our philanthropic partners,” Professor Young said.
“We were particularly pleased that the strength of the antibody response was even better than those observed in samples from COVID-19 recovered patients.”
https://www.doherty.edu.au/news-events/news/uq-covid-19-vaccine-shown-to-induce-potent-protective-response-in-pre-clinical-trials
